Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

Roskam, Davis Introduce Bill to Encourage Next Generation Antibiotics

Press Release

Location: Washington, DC

Today, Reps Peter Roskam (R-IL) and Danny Davis (D-IL) introduced H.R. 4187, the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act. This bipartisan legislation addresses the critical shortage of research and development for the production of advanced antibiotics that can treat resistant bacterial infections.

The Roskam-Davis legislation addresses each of the four "core actions" identified in a November 2013 report from the U.S. Centers for Disease Control (CDC) as critical to combating the looming healthcare crisis of antibiotic-resistant bacteria and reducing preventable deaths, including preventing infections and the spread of resistant bacteria, better tracking of resistance and antibiotic use, improved use of antibiotics, and the development of new antibiotics to treat resistant infections.

"I'm pleased to join my Illinois colleague Congressman Davis in introducing the DISARM Act, which works to remove barriers to the research and development of advanced antibiotics to effectively treat resistant infections," Congressman Roskam said. "At present, there is a significant unmet medical need for therapies that can effectively treat resistant infections, a situation that is very serious and has prompted alarm bells from our nation's best physicians and scientists, including those at the NIH and CDC. This legislation takes concrete steps to get companies back in the market to develop new antibiotics so that we can continue to stay on the leading edge of medicine and fight back against the superbugs that are increasingly impervious to even our toughest treatments."

"The CDC, the NIH and other leading national and international scientific bodies have expressed growing concern about the rapid spread of antibiotic resistance," Congressman Davis said. "Antibiotic resistance stems from a variety of causes ranging from the overuse and misuse of antibiotics in humans and animals, to genetic mutations and selective evolutionary pressures on bacteria arising from the widespread use of antibiotics. It is my hope that this legislation will become a part of a comprehensive, evidence-based response to this emerging threat."

Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Thank You!

You are about to be redirected to a secure checkout page.

Please note:

The total order amount will read $0.01. This is a card processor fee. Please know that a recurring donation of the amount and frequency that you selected will be processed and initiated tomorrow. You may see a one-time charge of $0.01 on your statement.

Continue to secure page »

Back to top